PathoQuest to participate in next BioPharma Asia webinar: VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS
VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS Together with product efficacy, product safety is an essential characteristic of any medicinal product including cell and gene therapy (C>) biologics. Adventitious agents (viruses, bacteria, mycoplasma,...
Save this Date – 3rd Annual PathoQuest NGS & Biosafety Workshop: October 1st, 2020 – Digital Event (Register Now)
Register below to attend the workshop There is no cost to register
Watch the replay of our webinar – Accelerated vaccines development and production: in-process NGS QC testing for risk mitigations
View an archived version of our recent webinar . Accelerated vaccines development and production: in-process NGS QC testing for risk mitigations Appropriate safety testing is an important part of vaccine development and production. As the impact of COVID-19 continues...
Watch the replay of our webinar – The Benefits of NGS-Based Quality Control for Routine Biologics testing using GLP-Certified Solutions
View an archived version of our recent webinar . The Benefits of NGS-Based Quality Control for Routine Biologics testing using GLP-Certified Solutions Next-generation sequencing (NGS) is a fast and reliable quality control test for adventitious agents' detection and...
Listen to the replay of our webinar – Optimizing Adventitious Virus Detection in Cells Using a New High-Throughput Sequencing Methodology
View an archived version of our recent webinar.Cell Testing for Adventitious Viruses: A Game Changing Approach using High-Throughput SequencingThe use of high-throughput sequencing (HTS) to identify viral contamination of biological products is extremely...
Upcoming Webinar – Cell Testing for Adventitious Viruses: A Game Changing Approach using High-Throughput Sequencing
You are invited to our upcoming webinar .Cell Testing for Adventitious Viruses: A Game Changing Approach using High-Throughput SequencingThe use of high-throughput sequencing (HTS) to identify viral contamination of biological products is extremely...
View our 2019 PathoQuest Workshop highlights video
The 2nd Annual PathoQuest Workshop focusing on "Industrial Applications of NGS to Viral Safety and Genetic Characterization of Biologics" was held on June 18, 2019 in Paris, France. The workshop featured presentations related to PathoQuest Biologics...
A video invitation to join us at PathoQuest’s 2nd Annual Workshop – June 18, 2019 in Paris, France
For more information about the workshop or to register, visit www.pathoquest.com/2019workshop.
Listen to the replay of our webinar – Using NGS to characterize cell lines used for production of biologics: Verifying clonality and identity
View an archived version of our recent webinar . Using NGS to characterize cell lines used for production of biologics: Verifying clonality and identity Regulatory authorities require high level of confirmation of the characteristics of a cell line...
PathoQuest providing sponsorship for the Third International Conference on Clinical Metagenomics (ICCMg3) – October 18-19, Geneva, Switzerland
PathoQuest will be a sponsor for the Third International Conference on Clinical Metagenomics (ICCMg3) being held 18 and 19 October 2018 in Geneva, Switzerland. PathoQuest will be represented at this meeting by our CEO, Jean-Francois Brepson, our Chief Scientific...